- Does Combination Therapy of Aspirin Plus Antiplatelet Therapy Increase the Risk of Upper Gastrointestinal Hemorrhage?
-
Kim JH
- KMID: 1718399
- Korean J Gastroenterol.
- 2011 Apr;57(4):205-206.
- doi: 10.4166/kjg.2011.57.4.205
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Gastroduodenal Injury in Patients with Low-Dose Enteric Coated Aspirin Treatment
-
Lee HL, Han DS, Kim JB, Park JY, Sohn JH, Hahm JS, Ahn YH
- KMID: 881582
- Korean J Gastroenterol.
- 2003 Sep;42(3):190-194.
BACKGROUND/AIMS: Low-dose aspirin therapy is widely used to prevent cardiovascular thrombotic events. However, the safety of low-dose aspirin therapy in the gastrointestinal tract is uncertain. Our aim was to evaluate... -
- CITED
-
- Close
- SHARE
-
- Close
- Characteristics of Colon Cancer Diagnosed in Patients Taking Aspirin or Warfarin
-
Shin SJ, Kim BC, Park S, Kim S, Kim TI, Kim WH
- KMID: 935196
- Korean J Gastroenterol.
- 2005 Dec;46(6):455-462.
BACKGROUND/AIMS: Warfarin and aspirin are commonly used to prevent cardiovascular diseases. Aspirin was recently found to have chemopreventive effects on colon cancer and polyps by inhibiting cyclooxygenase-2. Therefore, we evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Aspirin Alone or Aspirin Plus Additional Antiplatelets Therapy on Upper Gastrointestinal Hemorrhage
-
Bae SE, Kim SE, Jung SA, Yoon SY, Shim KN, Jung HK, Kim TH, Yoo K, Moon IH
- KMID: 1718401
- Korean J Gastroenterol.
- 2011 Apr;57(4):213-220.
- doi: 10.4166/kjg.2011.57.4.213
BACKGROUND/AIMS: The increasing incidence of cardiovascular disease has led to an increase in the frequency of upper gastrointestinal (GI) hemorrhage due to the use of antiplatelet agents. This study examined... -
- CITED
-
- Close
- SHARE
-
- Close
- Soy Protein Supplementation Reduces Clinical Indices in Type 2 Diabetes and Metabolic Syndrome
-
Zhang XM, Zhang YB, Chi MH
- KMID: 2374089
- Yonsei Med J.
- 2016 May;57(3):681-689.
- doi: 10.3349/ymj.2016.57.3.681
PURPOSE: Clinical trials have studied the use of soy protein for treating type 2 diabetes (T2D) and metabolic syndrome (MS). The purpose of this study was to outline evidence on... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of NF-kappaB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells
-
Jeong IK, Oh DH, Park SJ, Kang JH, Kim S, Lee MS, Kim MJ, Hwang YC, Ahn KJ, Chung HY, Chae MK, Yoo HJ
- KMID: 1058706
- Exp Mol Med.
- 2011 Dec;43(12):684-692.
- doi: 10.3858/emm.2011.43.12.079
Recent epidemiologic studies clearly showed that early intensive glucose control has a legacy effect for preventing diabetic macrovascular complications. However, the cellular and molecular processes by which high glucose leads... -
- CITED
-
- Close
- SHARE
-
- Close
